Donald A. Denkhaus, Director at CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX), bought 15,000 shares at $3.71 ($56K) on 2015-04-27, disclosed to the SEC on 2015-04-28.
Open-market purchase of $56k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CPRX | BUY | 2018-12-28 | $48K | — | Filing → |
| CPRX | BUY | 2018-12-17 | $149K | — | Filing → |
| CPRX | BUY | 2018-06-11 | $68K | — | Filing → |